-
Cancer Recurrence: Things to Be Mindful of When Cancer Returns
31 Jan 2023 11:07 GMT
… cancer include breast cancer, lung cancer, colon cancer, and prostate … .
All about cancer recurrence
Cancer recurrence, also known as … cancer include breast cancer, lung cancer, colon cancer, and … .
All about cancer recurrence
Cancer recurrence, also known as …
-
Merck gets USFDA nod for KEYTRUDA as adjuvant treatment for non-small cell lung cancer
30 Jan 2023 09:43 GMT
… reduced the risk of disease recurrence or death by 27% … and IIIA non-small cell lung cancer. Unfortunately, many of these … with non-small cell lung cancer following surgery and adjuvant … patients with non-small cell lung cancer.”
"With this approval, …
-
Merck's KEYTRUDA Gets FDA Approval To Treat Stage IB, II, IIIA Non-small Cell Lung Cancer Patients
27 Jan 2023 12:31 GMT
… , or IIIA non-small cell lung cancer or NSCLC.
With this approval … reduced the risk of disease recurrence or death by 27% in … of metastatic non-small cell lung cancer and has changed the way … KEYTRUDA in non-small cell lung cancer and the first indication for …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:12 GMT
… non-small cell lung cancer following surgery and … Platform (ETOP).
About lung cancer
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … these, 23% had recurrence. Pneumonitis resolved in …
-
FDA Approves KEYTRUDA® (pembrolizumab) as Adjuvant Treatment Following Surgical Resection and Platinum-Based Chemotherapy for Patients With Stage IB (T2a ≥4 Centimeters), II, or IIIA Non-Small Cell Lung Cancer (NSCLC)
27 Jan 2023 12:06 GMT
… non-small cell lung cancer following surgery and … Platform (ETOP).
About lung cancer
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer … these, 23% had recurrence. Pneumonitis resolved in …
-
FDA approves pembrolizumab as adjuvant treatment for non-small cell lung cancer
27 Jan 2023 00:31 GMT
… , or IIIA non-small cell lung cancer (NSCLC).
View full prescribing information … every 6 weeks until disease recurrence, unacceptable toxicity, or up to …
-
New Drug Therapy Approvals 2019
30 Jan 2023 20:27 GMT
… -squamous non-small cell lung cancer, glioblastoma, metastatic renal … to reduce the recurrence of symptomatic venous thromboembolism … squamous non-small cell lung cancer; glioblastoma (cancer originating … non-small cell lung cancer and locally advanced …
-
The Case for RRx-001 as a Radiation Countermeasure
30 Jan 2023 12:47 GMT
… for treatment of small cell lung cancer (SCLC)6 and in a … life but also tumor control, recurrence and survival.10
In a … in third-line small cell lung cancer. Future Oncol. 2019 Oct;15 …
-
US FDA approves Keytruda as adjuvant treatment following surgical resection and platinum─based chemotherapy for patients with stage IB (T2a =4 centimeters), II, or IIIA NSCLC
30 Jan 2023 07:49 GMT
… with non-small cell lung cancer following surgery and … v1.1-defined disease recurrence as determined by the … Oncology Platform (ETOP).
Lung cancer is the leading cause … lung cancer globally. Non-small cell lung cancer is the most common type of lung cancer …
-
Merck’s Keytruda Snags Fifth NSCLC Nod
27 Jan 2023 23:27 GMT
… or IIIA non-small cell lung cancer after resection or platinum-based … risk of death or disease recurrence.
In a statement, Roy S … patients still often see cancer recurrence, for which this latest Keytruda …
About
© 1995-2023